Johnson & Johnson ordered to pay man $8bn over breast growth  Sky NewsView full coverage on Google News
A US jury found that a subsidiary of the drug firm failed to highlight risks an anti-psychotic drug could lead to breast growth.A US jury found that a subsidiary of the drug firm failed to highlight risks an anti-psychotic drug could lead to breast growth.

Johnson & Johnson ordered to pay man $8bn over breast growth | Business News | Sky News

Court sides with man who argued company downplayed risks the drug could lead to breast growth in boysCourt sides with man who argued company downplayed risks the drug could lead to breast growth in boys

Johnson & Johnson fined $8bn over marketing of anti-psychotic drug

“Jury says Johnson & Johnson must pay US$8-billion in case over male breast growth linked to #Risperdal via ⁦@globebusiness⁩ https://t.co/EVIXgFzsYA”

André Picard on Twitter: "Jury says Johnson & Johnson must pay US$8-billion in case over male breast growth linked to #Risperdal via ⁦@globebusiness⁩ https://t.co/EVIXgFzsYA"

““jury on Tues­day or­dered John­son & John­son to pay $8 bil­lion in dam­ages to a Mary­land man who said his use of J&J’s an­tipsy­chotic Risperdal as a child caused en­larged breasts and the com­pany failed to prop­erly warn of this risk” https://t.co/S7Ew3yvQIN from @Loftus”

Arielle Duhaime-Ross (she/her) on Twitter: "“jury on Tues­day or­dered John­son & John­son to pay $8 bil­lion in dam­ages to a Mary­land man who said his use of J&J’s an­tipsy­chotic Risperdal as a child caused en­larged breasts and the com­pany failed to prop­erly warn of this risk” https://t.co/S7Ew3yvQIN from @Loftus… https://t.co/UsRujKYd1X"

“A Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a Maryland man who said his use of J&J’s antipsychotic Risperdal as a child caused enlarged breasts and the company failed to properly warn of this risk. https://t.co/IyvWwyONaV”

Paul Vieira on Twitter: "A Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a Maryland man who said his use of J&J’s antipsychotic Risperdal as a child caused enlarged breasts and the company failed to properly warn of this risk. https://t.co/IyvWwyONaV"

“Philly jury hands Johnson & Johnson $8 billion verdict in Risperdal case over male breast growth https://t.co/IEfD9pPmjI”

Herman Wong on Twitter: "Philly jury hands Johnson & Johnson $8 billion verdict in Risperdal case over male breast growth https://t.co/IEfD9pPmjI"

The Philadelphia jury deliberating in the first punitive damages trial over Johnson & Johnson's conduct in marketing the antispychotic drug Risperdal has slammed the company with an $8 billion verdict.The Philadelphia jury deliberating in the first punitive damages trial over Johnson & Johnson's conduct in marketing the antispychotic drug Risperdal has slammed the company with an $8 billion verdict.

Phila. Jury Returns $8 Billion Verdict Against Johnson & Johnson Over Risperdal | The Legal Intelligencer

Philly jury hits Johnson & Johnson with $8 billion verdict in Risperdal case over male breast growth | Pittsburgh Post-Gazette

Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.Johnson & Johnson must pay $8 billion in punitive damages to a man who previousl...

Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal - Reuters

A Pennsylvania jury ruled Tuesday that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that a psychiatric drug could cause breast growth in men.A Pennsylvania jury ruled Tuesday that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that a psychiatric drug could cause breast growth in men.

Johnson & Johnson Must Pay $8 Billion Over Drug Side Effect: Jury

A man has been awarded a huge payout after drugs he took for schizophrenia and bipolar disorder made him grow breasts. Johnson & Johnson and Janssen Pharmaceuticals were blamed for...Nicholas Murray was prescribed the drug as a child and went on to grow breasts.

Man wins $8bn Johnson and Johnson payout after Risperdal gave him breasts | Metro News

Subscribe to read | Financial Times

PHILADELPHIA (AP) — A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys.Johnson and Johnson immediately denounced the award after the jury's decision in the Court of Common pleas, saying it's "excessive and unfounded" and vowing immediate action to overturn it.The antipsychotic drug Risperdal is at the center of the lawsuit, with the plaintiff's attorneys arguing it's linked to abnormal growth of female breast tissue in boys, an incurable condition known as gynecomastia.OCT 8, 2019 - PHILADELPHIA (AP) — A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the...

Johnson & Johnson, Risperdal maker hit with $8B verdict

A Pennsylvania jury ruled Tuesday that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that a psychiatric drug could cause breast growth in men.  A Pennsylvania jury ruled Tuesday that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that a psychiatric drug could cause breast growth in men. 

J&J must pay $8B in case over male breast growth side effect: jury | ABS-CBN News

NEW YORK (REUTERS) - Johnson & Johnson must pay US$8 billion (S$11 billion) in punitive damages to a man who previously won US$680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday (Oct 8).. Read more at straitstimes.com.United States News -NEW YORK (REUTERS) - Johnson & Johnson must pay US$8 billion (S$11 billion) in punitive damages to a man who previously won US$680,000 over his claims that it failed to warn that

Jury says Johnson & Johnson must pay US$8 billion in case over male breast growth linked to Risperdal, United States News & Top Stories - The Straits Times

Johnson & Johnson and its subsidiary Janssen Pharmaceuticals were blamed as plaintiff Nicholas Murray told the Philadelphia court that the drug Risperdal, prescribed to treat schizophrenia and bipolar disorder, had made him grow breasts.Johnson & Johnson and its subsidiary Janssen Pharmaceuticals were blamed as plaintiff Nicholas Murray told the Philadelphia court that the drug Risperdal, prescribed to treat schizophrenia and bipolar disorder, had made him grow breasts.

Johnson & Johnson ordered to pay $8 billion over drug side effect | world news | Hindustan Times

In New Zealand, the drug is called Risperidone.In New Zealand, the drug is called Risperidone.

Johnson & Johnson hit with $12b verdict over drug possibly linked to growth of female breast tissue in boys | 1 NEWS NOW | TVNZ

Johnson & Johnson must pay US$8 billion in punitive damages to a man who previously won US$680,000 over his claims that it failed to warn that ...Johnson & Johnson must pay US$8 billion in punitive damages to a man who previously won US$680,000 over his claims that it failed to warn that ...

Johnson & Johnson must pay US$8 billion in male breast growth lawsuit: Jury - CNA

J&J said it would appeal the decision.J&J said it would appeal the decision.

Johnson & Johnson Ordered To Pay $8 Billion In Male Breast Growth Case

404 Not Found

The Philadelphia Common Pleas Court jury agreed that Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, illegally marketed the drug to pediatric physicians despite knowing its dangers.The Philadelphia Common Pleas Court jury agreed that Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, illegally marketed the drug to pediatric physicians despite knowing its dangers.

Philly jury hands Johnson & Johnson $8 billion verdict in Risperdal case over male breast growth